Coronavirus BRIEFING
Supported by Essilor

The Latest COVID-19 Data

The National Average for Gross Revenue at ECP Locations Increased for the Week of May 15 – 21, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Thursday, May 25, 2023 12:27 AM NEW YORK—The national average for gross revenue at ECP locations increased last week, May 15 – 21, when compared with the previous week at a rate of 1 index point. That places gross revenue at a level 7 index points above where it was at this point in time (Week 21) when compared with last year (2022), 11 points above the same period in 2021, 31 points above 2020 (when COVID stay-at-home restrictions were in place), and 19 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

Could Vitamin D Supplementation Help in Long COVID?

By Staff
Wednesday, May 17, 2023 8:02 AM Patients with long COVID-19—where the effects of an initial COVID infection last more than 12 weeks—had lower levels of 25(OH) vitamin D than other patients who survived COVID-19, in a retrospective, case-matched study.

The National Average for Gross Revenue at ECP Locations Decreased for the Week of May 8 – 14, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Wednesday, May 17, 2023 12:27 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, May 8 – 14, when compared with the previous week at a rate of -2 index points. That places gross revenue at a level 4 index points above where it was at this point in time (Week 20) when compared with last year (2022), 11 points above the same period in 2021, 46 points above 2020 (when COVID stay-at-home restrictions were in place), and 16 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

Behavioral Therapy Reduces Long COVID Fatigue, Study Says

By Staff
Tuesday, May 16, 2023 8:03 AM People with long COVID significantly reduced their fatigue after completing 17 weeks of cognitive behavioral therapy, compared to people with similar long COVID fatigue levels who didn't participate in therapy, a new study shows.

G7 Plans New Vaccine Effort for Developing Nations, Yomiuri Reports

By Staff
Tuesday, May 16, 2023 8:02 AM TOKYO—The Group of Seven (G7) rich nations is set to agree on establishing a new program to distribute vaccines to developing countries at next week's summit of leaders, Japan's Yomiuri newspaper said on Saturday.

After Backlash, Feds Extend Pandemic Telehealth Rules for Controlled Drugs Until November

By Staff
Monday, May 15, 2023 8:02 AM Facing pushback from clinicians and patients, the US Drug Enforcement Administration (DEA) has extended through November temporary pandemic rules for physicians and clinicians dispensing controlled drugs. The rules, which allow prescriptions of controlled medications or buprenorphine without an in-person visit, were set to end when the federal public health emergency ends May 11.

Sleep Apnea Patients Prone to Higher Long COVID Risk

By Staff
Monday, May 15, 2023 6:09 AM Preexisting obstructive sleep apnea (OSA) was associated with up to a 75% increased risk of long COVID in adults, an analysis from the NIH RECOVER collaboration found.

Here's How We Can Rebuild Trust in Vaccines

By Staff
Friday, May 12, 2023 8:02 AM When people ask Paul Offit, MD, what worries him the most about the COVID-19 pandemic, he names two concerns. "One is the lack of socialization and education that came from keeping kids out of school for so long," Offit told Medscape Medical News in a recent interview. "And I think vaccines have suffered."

Post-COVID, Building 'Health' Matters, Too

By Staff
Friday, May 12, 2023 7:59 AM In 2017, Shangwen Kennedy, an experienced, Harvard-trained architect and urban designer, wanted to try something new: Creating spaces that would improve the health and well-being of people who use them.

FDA Recalls 500,000 COVID Test Kits Due to Bacteria

By Staff
Thursday, May 11, 2023 7:59 AM As many as half a million at-home COVID tests are being recalled due to potential bacterial contamination.

The National Average for Gross Revenue at ECP Locations Remained Flat for the Week of May 1 – 7, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Thursday, May 11, 2023 12:27 AM NEW YORK—The national average for gross revenue at ECP locations remained flat last week, May 1 – 7, when compared with the previous week. That places gross revenue at a level 4 index points above where it was at this point in time (Week 19) when compared with last year (2022), 11 points above the same period in 2021, 66 points above 2020 (when COVID stay-at-home restrictions were in place), and 17 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

Consumers Holding Onto Pandemic Purchasing Habits

By Staff
Wednesday, May 10, 2023 2:37 PM The pressure is on this year as consumers become much more selective about their purchases. While price is a key factor in purchasing decisions, it's not the only thing that is swaying these careful consumers.

CDC to Scale Back Data Collection as US Ends COVID Health Emergency

By Staff
Wednesday, May 10, 2023 8:02 AM The U.S. Centers for Disease Control and Prevention (CDC) said on Friday it would stop reporting or monitoring COVID-19 case data and transmission rates after the government ends the pandemic's public health emergency designation next week.

For Long COVID Parents, Everyday Life Is Still a Struggle

By Staff
Wednesday, May 10, 2023 7:59 AM Brooke Keaton, 42, of Charlotte, NC, has a back-up plan for the bad days. She calls them “her long COVID days” and when she has one, her husband knows she’s too fatigued to play with their two daughters, ages 12 and 5.

COVID Drops to Fourth Place in Causes of Death in U.S.

By Staff
Tuesday, May 9, 2023 7:59 AM The number of deaths caused by COVID was more than halved in 2022, compared to the toll the virus wrought in 2021, according to new CDC data. The decline drops COVID from third place to fourth place as a leading cause of death in the U.S.